ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $327 | +1386.4% | 162 | -98.2% | 0.00% | -100.0% |
Q1 2023 | $22 | -68.6% | 8,821 | -59.8% | 0.00% | -66.7% |
Q4 2022 | $70 | -99.9% | 21,966 | +22.1% | 0.00% | +200.0% |
Q3 2022 | $53,000 | +783.3% | 17,991 | +853.9% | 0.00% | – |
Q2 2022 | $6,000 | -68.4% | 1,886 | +37.1% | 0.00% | – |
Q1 2022 | $19,000 | +90.0% | 1,376 | +83.7% | 0.00% | – |
Q4 2021 | $10,000 | -69.7% | 749 | -78.4% | 0.00% | -100.0% |
Q3 2021 | $33,000 | +17.9% | 3,462 | +28.0% | 0.00% | 0.0% |
Q2 2021 | $28,000 | +40.0% | 2,704 | +144.3% | 0.00% | – |
Q1 2021 | $20,000 | +42.9% | 1,107 | +172.0% | 0.00% | – |
Q4 2020 | $14,000 | – | 407 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |